Results 201 to 210 of about 563,660 (283)
Exploring the limited use of transdermal medications in psychiatry: Challenges and potential solutions. [PDF]
World J MethodolKaur M, Patel M, Monis E.
europepmc +1 more source
Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges. [PDF]
Bioact MaterCao X, He R, Xu D, Zhao Y.
europepmc +1 more source
Approach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary Syndrome.
J Clin Endocrinol MetabJoham AE +4 more
europepmc +1 more source
Testosterone patch increases sexual activity in women with hypoactive sexual desire disorder
Nature Clinical Practice Endocrinology & Metabolism, 2005 Testosterone patch increases sexual activity in women with hypoactive sexual desire ...
Marie Lofthouse
semanticscholar +4 more sources
Testosterone-Patch-Induced Psychotic Mania
American Journal of Psychiatry, 1999 Erica L. Weiss +2 more
semanticscholar +5 more sources
Transdermal testosterone delivery: testosterone patch and gel [PDF]
World Journal of Urology, 2003 Testosterone replacement treatment is usually life-long. Fortunately, testosterone administration is relatively safe and until the age of 50 years few side effects are noted with normal doses of testosterone. After the age of 50 years when prostate disease becomes more prevalent, shorter-acting testosterone preparations, allowing a fast reduction of ...
L. Gooren, M. Bunck
semanticscholar +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Images in clinical medicine. Eschar formation from testosterone patch.
New England Journal of Medicine, 2012A 78-year-old man presented for his yearly skin exam and was noted to have an oval-shaped, green-black eschar on his midback. A pink, atrophic scar was located nearby, in addition to a medicated patch of similar size.
C. Orme, S. Imaeda
semanticscholar +4 more sources
Testosterone patch launched in the UK
Inpharma Weekly, 1996 NULL AUTHOR_ID
semanticscholar +3 more sources
Testosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial
Obstetrics & Gynecology, 2005To assess the efficacy and safety of a 300 mug/d testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women on concomitant estrogen therapy.Five hundred thirty-three women with hypoactive sexual desire disorder who had undergone previous hysterectomy and bilateral oophorectomy were enrolled in a 24-week ...
J. Buster +8 more
semanticscholar +5 more sources